cbdMD (YCBD) Cash from Operations (2016 - 2025)
cbdMD (YCBD) reported Cash from Operations of 812464.0 for Q4 2025, down 155.53% on a YoY basis from 1463034.31 in Q4 2024, and down 237.47% sequentially from 240749.0 in Q3 2025.
cbdMD (YCBD) Cash from Operations (2016 - 2025) Analysis & Trends
cbdMD (YCBD) has 10 years of Cash from Operations data on file, last reported at 812464.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Operations fell 155.53% year-over-year to 812464.0; the trailing twelve-month figure through Dec 2025 stood at 1946890.0 (down 244.67% YoY), and the FY2025 full-year result was 1452375.0, down 311.68% from the prior year.
- Cash from Operations fell to 812464.0 in Q4 2025, from 240749.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 289779.0 in Q2 2024 to a low of 5468475.0 in Q4 2021.
- A 5-year average of 1689411.35 and a median of 758332.0 in 2025 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations slumped 1019.2% in 2021 and soared 220.45% in 2024, its largest moves.
- Tracing YCBD's Cash from Operations over 5 years: stood at 5468475.0 in 2021, then surged by 62.25% to 2064357.0 in 2022, then jumped by 94.87% to 105880.0 in 2023, then sank by 200.29% to 317949.0 in 2024, then tumbled by 155.53% to 812464.0 in 2025.
- Business Quant data shows YCBD's Cash from Operations at 812464.0 in Q4 2025, 240749.0 in Q3 2025, and 704200.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | -812,464.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -812,464.00 |
| Dec 31, 2025 | -812,464.00 |
| Sep 30, 2025 | -240,749.00 |
| Sep 30, 2025 | -240,749.00 |
| Jun 30, 2025 | -704,200.00 |
| Jun 30, 2025 | -704,200.00 |
| Mar 31, 2025 | -189,477.00 |
| Mar 31, 2025 | -189,477.00 |
| Dec 31, 2024 | -317,949.00 |
| Dec 31, 2024 | -317,949.00 |
| Sep 30, 2024 | 167,377.00 |
| Sep 30, 2024 | 167,377.00 |
| Jun 30, 2024 | 289,779.00 |
| Jun 30, 2024 | 289,779.00 |
| Mar 31, 2024 | -704,068.00 |
| Mar 31, 2024 | -704,068.00 |
| Dec 31, 2023 | -105,880.00 |
| Dec 31, 2023 | -105,880.00 |
| Sep 30, 2023 | -263,501.00 |
| Sep 30, 2023 | -263,501.00 |